Kratom vs. CBD: A Botanical and Chemical Comparison
Kratom and CBD increasingly appear side by side in discussions about plant-based alternative compounds. That is understandable – both are botanical in origin, both move within legal grey areas, and both have attracted considerable attention in recent years.
But that is where the similarities end. Chemically, botanically and legally, kratom and CBD are fundamentally different. This article explains those differences – without any claims about effects, purely on the basis of plant science and chemistry.
The plants: where do they come from?
Kratom comes from Mitragyna speciosa, a tree of the Rubiaceae family (the madder family) – the same family as coffee. The plant grows natively in the tropical rainforests of Southeast Asia, above all in Thailand, Malaysia, Indonesia and Papua New Guinea. What is harvested are the leaves, which are then dried, powdered or extracted.
CBD (cannabidiol) comes from Cannabis sativa, the hemp plant. It belongs to the Cannabaceae family and is distributed worldwide across temperate to tropical climate zones. CBD is obtained above all from industrial hemp (with a very low THC content), mainly from the flowers and leaves of the plant.
Even at this point it is clear: these two plants have nothing to do with one another. They come from different continents, from different plant families, and they have completely different botanical properties.
The active compounds: alkaloids vs. cannabinoids
This is the decisive chemical difference:
| Property | Kratom (mitragynine) | CBD (cannabidiol) |
|---|---|---|
| Compound class | Indole alkaloid | Cannabinoid |
| Source plant | Mitragyna speciosa | Cannabis sativa |
| Plant family | Rubiaceae | Cannabaceae |
| Solubility | Lipophilic (fat-soluble) | Lipophilic (fat-soluble) |
| Nitrogen in the molecule | Yes (typical for alkaloids) | No |
| Known receptor interaction | μ-opioid receptor (partial) | CB1/CB2 receptors, others |
Alkaloids are nitrogen-containing organic compounds – like caffeine, nicotine or morphine. Cannabinoids are terpenophenolic compounds that contain no nitrogen atom at all and are structurally built in a completely different way.
Viewed soberly, the chemical similarity between mitragynine and CBD is close to non-existent.
Legal status in Germany and the EU
CBD:
- Cannabidiol is regulated in Germany and across the EU as a food ingredient under Novel Food (actively enforced since 2019)
- Sold as a food, CBD products require a Novel Food authorization
- Pure CBD is not listed in the German Narcotics Act (BtMG)
- CBD products (oils, capsules, foods) sit in a legal grey area – the market is large, but regulation is inconsistent
Kratom:
- Kratom (Mitragyna speciosa) is likewise not listed in the BtMG – possession and sale in Germany are legal
- Kratom is also subject to the Novel Food Regulation, which means that sale as a food is not permitted without authorization
- Kratom products are therefore distributed with the notice “not intended for human consumption”
- The legal situation depends on the country – in several EU member states kratom is restricted or banned
Ironically, CBD and kratom find themselves within a very similar legal framework: both wrestle with the Novel Food Regulation, neither has a clear status as a food supplement, and both are frequently marketed through the same regulatory channel (botanical product, not intended for consumption).
Market development: two different trajectories
CBD has seen considerable market expansion in recent years. In Europe alone the CBD market is estimated at several billion euros. Large corporations are investing, supermarkets list CBD products – public acceptance is high.
The European market for Mitragyna speciosa products is distinctly smaller; public awareness of the plant remains low in Europe.
Are kratom and CBD combined?
Some international products do contain kratom and CBD together. From a chemical point of view this simply means two compounds from two different plants mixed into one product. There are no scientifically established data on interactions between mitragynine and CBD at the receptor level.
Note: This article describes only the botany and chemistry of the two plants and makes no statements about health effects.
Conclusion
Kratom and CBD are two different plants with two chemically fundamentally different classes of active compound. What connects them: both are extracted botanically, both have moved within the same regulatory grey area of the Novel Food Regulation, and both attract growing interest as plant-based alternative materials. What separates them: everything else – botany, chemistry, origin, receptor profile and market development.
Further reading
- What Is an Alkaloid? Caffeine, Nicotine, Mitragynine – A Clear Overview
- What is mitragynine ?
- What is 7-hydroxymitragynine ?
- Kratom and Novel Food: What the EU Regulation Means for Buyers and Sellers
Legal notice
This article is for informational purposes only and does not constitute legal advice. Its content is not intended to encourage consumption. Laws may change; the applicable regulations and information from official bodies are authoritative. Image source: https://www.kratoein.com/